A Phase 2 Randomized Trial of Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Panitumumab (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- Acronyms CONCERT-2
- Sponsors Amgen
- 02 Oct 2012 Results presented at the 37th Congress of the European Society for Medical Oncology.
- 02 Oct 2012 Patient numbers updated to 151
- 02 Oct 2012 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History